We invite patients with severe plaque psoriasis to pre-selection to participate in the study of a new genetically engineered drug. The treatment period is 1 year, all examinations and observations are free of charge

Started protocol with healthy volunteers aged 18-60 years, vaccinated with ADS-M more than 10 years ago, to participate in a clinical trial of a new vaccine against diphtheria, pertussis and tetanus. aAKDS-M is compared with the Adacel vaccine, there is no placebo

Our partners

Protagonist
Gilead
Mithra
PRA Health Sciences
Pfizer
Rusmo-AG
Sanofi
Abbvie
Icon
Astra Zeneca
Gedeon Richter
Cromos Pharma
PPD
X7 Research
Synteract
IQVIA
Biorasi | Built for Faster Clinical Trials
PSI
ALK
Galecto
SRG
Clinipas
Astellas
Janssen
JonsonAndJonson
OCT
Celgen
Bristol-Myers Squibb Company
Biogen